Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
21.27
-0.29 (-1.35%)
Nov 20, 2024, 4:00 PM EST - Market closed
Company Description
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States.
Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
The company was founded in 2003 and is based in Atlanta, Georgia.
Guardian Pharmacy Services, Inc.
Country | United States |
Founded | 2004 |
IPO Date | Sep 26, 2024 |
Industry | Pharmaceutical Retailers |
Sector | Healthcare |
Employees | 2,900 |
CEO | Fred Burke |
Contact Details
Address: 300 Galleria Parkway SE, Suite 800 Atlanta, Georgia 30339 United States | |
Phone | 404 810 0089 |
Website | guardianpharmacy.com |
Stock Details
Ticker Symbol | GRDN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $14.00 |
CIK Code | 0001802255 |
ISIN Number | US40145W1018 |
Employer ID | 20-0100834 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Fred Burke | President and Chief Executive Officer |
David Morris | Executive Vice President and Chief Financial Officer |
Kendall Forbes | Executive Vice President of Sales & Operations |
William Bindley | Chairman of the Board of Directors |
John Ackerman | Class II Director |
Steve Cosler | Class III Director |
Randall Lewis | Class II Director |
Mary Sue Patchett | Class I Director |
Thomas Salentine, Jr. | Class I Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SCHEDULE 13G | Filing |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Oct 31, 2024 | SCHEDULE 13G | Filing |
Oct 31, 2024 | SCHEDULE 13G | Filing |